March 30 Inovio Pharmaceuticals Inc
* Inovio pharma-co's academic, industry collaborators received multi-year $6.95 million grant from nih's national institute of allergy & infectious diseases
* Inovio-Grant to develop single or combination therapy using co's pennvax-gp with goal of attaining long-term hiv remission in absence of antiviral drugs Source text for Eikon: Further company coverage:
U.S. IRS probes drug company-funded patient assistance charity
BOSTON, June 29 The U.S. Internal Revenue Service is probing whether a patient-assistance charity wrongly gave a benefit to its pharmaceutical company donors by returning most of the money they donated as payments for drugs they make, court papers show.